Research Participant Interest in Alzheimer’s Disease Biomarker Disclosure

Researchers can characterize the pathophysiological progression of Alzheimer’s disease (AD) even in the absence of symptoms. As we better understand the role of biomarker accumulation in the clinical manifestation of AD, disclosing personal biomarker information will become increasingly relevant. Ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Erickson, Claire, Chin, Nathaniel, Gleason, Carey, Johnson, Sterling, Clark, Lindsay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7740391/
http://dx.doi.org/10.1093/geroni/igaa057.3251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7740391/
http://dx.doi.org/10.1093/geroni/igaa057.3251

Ejemplares similares